Mobile application to monitor quality of ICU care nationwide (CHITRA)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2014 - 2014
Project Lead
Dr. Tony D S Raj, Dr. Sriram Sampath, Dr. Abijeet V Waghmare
Authors
Dr. Tony D S Raj, Dr. Sriram Sampath, Dr. Abijeet V Waghmare
Project Status
completed
Project Type
Indian Society of Critical Care Medicine